Acute dystonia with concomitant use of amitriptyline and paroxetine

Acute dystonia with concomitant use of amitriptyline and paroxetine

Amitriptyline and paroxetine are antidepressant agents useful for the treatment depressive disorders. Antidepressant induced extrapyramidal symptoms represent an under recognised but important clinical entity as it can adversely impact treatment adherence. Cases of acute dystonia have been reported...

Full description

Bibliographic Details
Main Authors:	Sachin Ratan Gedam, Arvind Goyal, Imran Ali Shivji
Format:	Article
Language:	English
Published:	Academy Publisher 2017-01-01
Series:	Open Journal of Psychiatry and Allied Sciences
Subjects:	Antidepressive Agents Depressive Disorder. Extrapyramidal symptoms. Serotonin Uptake Inhibitors. Depressive Disorder Extrapyramidal symptoms. Serotonin Uptake Inhibitors. Extrapyramidal symptoms Serotonin Uptake Inhibitors.
Online Access:	http://www.ojpas.com/get_file.php?id=31550121&vnr=640426

Similar Items

Fluxetine-induced extrapyramidal symptoms in an adolescent: a case report
by: RS Diler, et al.
Published: (2002-03-01)

Amitriptyline induced cervical dystonia
by: Shivanand B Hiremath, et al.
Published: (2016-01-01)

Extrapyramidal symptoms as a consequence of organophosphate poisoning: Insights from a clinical case
by: J. Martins Correia, et al.
Published: (2021-04-01)

Fluoxetine-induced blurring of vision: a rare ocular side effect
by: Namita Deka, et al.
Published: (2017-06-01)

Role of COMT V158M Polymorphism in the Development of Dystonia after Administration of Antipsychotic Drugs
by: Antonio Gennaro Nicotera, et al.
Published: (2021-09-01)

Adding pre-emptive anticholinergics to antipsychotics: Is it justified?
by: Kaushik Chatterjee, et al.
Published: (2022-01-01)

Rare presentation of a common disease: Idiopathic hypoparathyroidism presenting with extrapyramidal symptoms and status epilepticus
by: Kaushik Ghosh, et al.
Published: (2012-01-01)

Abdominal Wall Dyskinesia: Case Report
by: Leyla Cavdar, et al.
Published: (2020-02-01)

Pharmacological profile of prescriptions containing antidepressants
by: Prafull Mohan, et al.
Published: (2021-01-01)

Prozac and the new antidepressants : what you need to know about prozac, zoloft, paxil, luvox, wellbutrin, effexor, serzone, and more /
by: 329420 Appleton, William S.
Published: (1997)

The Implications of Adverse Pharmacologic Reactions and Complex Pathogenic Mechanisms in Schizophrenia
by: Puiu Olivian Stovicek, et al.
Published: (2021-08-01)

Metoclopramide in Gastroparesis: Its Mechanism of Action and Safety Profile
by: M Ammar Kalas, et al.
Published: (2023-08-01)

Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study
by: Giammarco Cascino, et al.
Published: (2022-10-01)

The Implications of Adverse Pharmacologic Reactions and Complex Pathogenic Mechanisms in Schizophrenia
by: Puiu Olivian Stovicek, et al.
Published: (2021-07-01)

Characterization of neurological soft signs in a Brazilian sample of stable patients with schizophrenia
by: Vinicius Sousa Pietra Pedroso, et al.
Published: (2018-09-01)

Efficacy of low-dose D2/D3 partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study
by: Weng JJ, et al.
Published: (2019-08-01)

Mood disorder with mixed, psychotic features due to vitamin b12 deficiency in an adolescent: case report
by: Tufan Ali, et al.
Published: (2012-06-01)

Drug-induced dystonia
by: T. M. Ostroumova, et al.
Published: (2020-10-01)

A descriptive analysis of spontaneous reports of antipsychotic‐induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database
by: Yosuke Saga, et al.
Published: (2024-03-01)

Efficacy and safety of prophylactic use of benzhexol after risperidone treatment
by: Kai Zhang, et al.
Published: (2023-03-01)

Clinical assessment of antipsychotic-induced extrapyramidal symptoms in nursing home residents with schizophrenia
by: Karol Woźniak, et al.
Published: (2016-03-01)

A Response to: "A Commentary on Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders.
by: Stephane ePotvin, et al.
Published: (2015-08-01)

Risperidone-induced tardive akathisia: A rare antipsychotic side effect with management issues
by: Biswa Ranjan Mishra, et al.
Published: (2019-01-01)

Commentary: Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.
by: Eiko I Fried, et al.
Published: (2015-08-01)

Parkinson's disease and related disorders /
by: Riederer, P. (Peter)
Published: (2006)

Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational Study
by: Hyun Jun Park, MD, PhD, et al.
Published: (2017-06-01)

Ifosfamide-induced extrapyramidal neurotoxicity with COVID-19
by: Chitrakshi Nagpal, et al.
Published: (2023-01-01)

Oleanolic acid alleviates the extrapyramidal symptoms and cognitive impairment induced by haloperidol through the striatal PKA signaling pathway in mice
by: Chang Hyeon Kong, et al.
Published: (2023-12-01)

Modification and evaluation of tools for pharmaceutical care of patients with schizophrenia in non-psychiatric hospitals
by: Kanchana Hattasin, et al.
Published: (2018-06-01)

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
by: Chang YP, et al.
Published: (2019-07-01)

Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
by: Caroline W. Espinola, et al.
Published: (2022-05-01)

Drug-Resistant Hyponatremia after Escitalopram Intake: A Series of Two Case Reports
by: Justyna Kacperczyk, et al.
Published: (2021-09-01)

The use of LeuT as a receptor model for antidepressant development
by: Lina Rustanti
Published: (2012-07-01)

Study of adverse effects of extrapyramidal syndrome use of combination of antipsychotics antidepressants in outpatient schizophrenia patients in RSUP Fatmawati for the period 2016-2020
by: Ema Nillafita Putri Kusuma, et al.
Published: (2023-07-01)

Descriptive epidemiological study on patients with movement disorders, with emphasis on Parkinson’s disease
by: Luiza Serafini Balestrassi, et al.
Published: (2021-01-01)

Dystonija caused with metoklopramid in emergency medical service: Case report
by: Đurđević Dimitije A.
Published: (2021-01-01)

Case series of drug-induced open bite: Extrapyramidal symptoms related to psychotropic medications
by: Motoko Watanabe, et al.
Published: (2023-03-01)

Interleukin-6 in schizophrenia is associated with negative symptoms, side effects of therapy and smoking: results of a pilot study
by: T. V. Zhilyaeva, et al.
Published: (2022-07-01)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
by: Ichinose M, et al.
Published: (2021-04-01)

A refractory head tremor appearing after volatile anesthesia combined with epidural anesthesia in a patient with spinocerebellar ataxia type 6
by: Takaya Nishida, et al.
Published: (2018-01-01)